The Terminally Ill Need More Than the ‘Right to Try’

After decades of medical research, why is chemotherapy still a mainstay for cancer patients?
Why do many Alzheimer’s patients still slide inexorably into helplessness?
How did developing a new drug become a multi-billion dollar venture that can take a decade or more?
Regulators, including at the Food and Drug Administration, have shackled every aspect of drug development under the guise of doing no harm.
But how exactly does it “harm” patients facing certain death to provide them with…
Read the Full Story at www.wsj.com